The global cell culture plates market is experiencing robust growth, driven by increasing demand in biotechnology and pharmaceutical research. As scientific advancements continue to revolutionize drug discovery, vaccine production, and regenerative medicine, the need for high-quality cell culture solutions has escalated. The market is anticipated to witness substantial expansion, with a projected CAGR of 7.5% from 2024 to 2032, reaching a valuation of USD 8.3 billion by 2032.